Overview
PURE market data
Price History
No market bars yet for PURE. This page will populate once the next provider sweep lands.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.02 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.22 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.04 – $0.14 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $9.1 · P/B 34.80 · P/S 3.75.
Company News
PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $506.000K Up From $491.000K YoYBenzinga · Jun 15, 2026, 9:30 PM
8-K filing — PURE BIOSCIENCE, INC. (PURE)SEC EDGAR · Jun 15, 2026, 8:05 PM